These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 17095916)

  • 41. Effects of long-term nicorandil administration on endothelial function, inflammation, and oxidative stress in patients without coronary artery disease.
    Ishibashi Y; Takahashi N; Tokumaru A; Karino K; Sugamori T; Sakane T; Yoshitomi H; Sato H; Oyake N; Murakami Y; Shimada T
    J Cardiovasc Pharmacol; 2008 Mar; 51(3):311-6. PubMed ID: 18356697
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of simultaneous pancreas and kidney transplantation on cardiovascular risk factors in patients with type 1 diabetes mellitus.
    Luan FL; Miles CD; Cibrik DM; Ojo AO
    Transplantation; 2007 Aug; 84(4):541-4. PubMed ID: 17713440
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Microsomal triglyceride transfer protein inhibition-friend or foe?
    Joy TR; Hegele RA
    Nat Clin Pract Cardiovasc Med; 2008 Aug; 5(8):506-8. PubMed ID: 18506153
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Rubric: Viewpoint--Revue médicale de la Suisse Romande 109: 1051-1052, 1989. Response to Dr. F. Pilet].
    Rev Med Suisse Romande; 1990 Mar; 110(3):297-9. PubMed ID: 2336514
    [No Abstract]   [Full Text] [Related]  

  • 45. Effect of different contraceptive methods on the oxidative stress status in women aged 40 48 years from the ELAN study in the province of Liege, Belgium.
    Pincemail J; Vanbelle S; Gaspard U; Collette G; Haleng J; Cheramy-Bien JP; Charlier C; Chapelle JP; Giet D; Albert A; Limet R; Defraigne JO
    Hum Reprod; 2007 Aug; 22(8):2335-43. PubMed ID: 17584753
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oxidative stress, inflammation and cardiovascular disease in chronic renal failure.
    Cottone S; Lorito MC; Riccobene R; Nardi E; Mulè G; Buscemi S; Geraci C; Guarneri M; Arsena R; Cerasola G
    J Nephrol; 2008; 21(2):175-9. PubMed ID: 18446711
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bioactive effects of olive oil phenolic compounds in humans: reduction of heart disease factors and oxidative damage.
    Covas MI
    Inflammopharmacology; 2008 Oct; 16(5):216-8. PubMed ID: 18815741
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Introduction. Oxidative stress and heart disease.
    Bhatt DL; Pashkow FJ
    Am J Cardiol; 2008 May; 101(10A):1D-2D. PubMed ID: 18474267
    [No Abstract]   [Full Text] [Related]  

  • 49. Editorial. The oxidant hypothesis of VCD.
    Shah PK
    Am J Cardiol; 2008 May; 101(10A):3D. PubMed ID: 18474270
    [No Abstract]   [Full Text] [Related]  

  • 50. Bibliography. Current world literature. Hyperlipidaemia and cardiovascular disease.
    Curr Opin Lipidol; 2002 Aug; 13(4):421-35. PubMed ID: 12180430
    [No Abstract]   [Full Text] [Related]  

  • 51. Influence of antiretroviral therapy on oxidative stress and cardiovascular risk: a prospective cross-sectional study in HIV-infected patients.
    Masiá M; Padilla S; Bernal E; Almenar MV; Molina J; Hernández I; Graells ML; Gutiérrez F
    Clin Ther; 2007 Jul; 29(7):1448-55. PubMed ID: 17825696
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A matter of degree: a commentary on "Influence of oxidized low-density lipoproteins (LDL) on the viability of osteoblastic cells".
    Demer LL; Tintut Y
    Free Radic Biol Med; 2008 Feb; 44(4):504-5. PubMed ID: 18005672
    [No Abstract]   [Full Text] [Related]  

  • 53. Hyperlipidaemia and cardiovascular disease.
    Cozma LS
    Curr Opin Lipidol; 2002 Apr; 13(2):227-9. PubMed ID: 11891426
    [No Abstract]   [Full Text] [Related]  

  • 54. Risk factors for cardiovascular disease in women: relationship to lipid peroxidation and oxidative stress.
    Castelao JE; Gago-Dominguez M
    Med Hypotheses; 2008; 71(1):39-44. PubMed ID: 18308480
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hyperlipidaemia and cardiovascular disease.
    Roberts AW; Morris K
    Curr Opin Lipidol; 2005 Apr; 16(2):253-5. PubMed ID: 15767865
    [No Abstract]   [Full Text] [Related]  

  • 56. Reducing CVD risk.
    Aranjo C
    Aust Fam Physician; 2008 Sep; 37(9):695. PubMed ID: 18837159
    [No Abstract]   [Full Text] [Related]  

  • 57. Protective effect of lycopene in cardiovascular disease.
    Riccioni G; Mancini B; Di Ilio E; Bucciarelli T; D'Orazio N
    Eur Rev Med Pharmacol Sci; 2008; 12(3):183-90. PubMed ID: 18700690
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Management of hyperlipidemia in older adults.
    Alexander KP; Blazing MA; Rosenson RS; Hazard E; Aronow WS; Smith SC; Ohman EM
    J Cardiovasc Pharmacol Ther; 2009 Mar; 14(1):49-58. PubMed ID: 19124599
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Bioactive isoprostanes. New markers of oxidative stress and inflammation-related diseases].
    Basu S; Helmersson J
    Lakartidningen; 2009 Jan 28-Feb 3; 106(5):274-8. PubMed ID: 19271455
    [No Abstract]   [Full Text] [Related]  

  • 60. Hyperlipidaemia and cardiovascular disease: nonlipid-lowering effects of omega-3 fatty acids, statins and fibrates.
    Dominiczak M
    Curr Opin Lipidol; 2009 Feb; 20(1):79-81. PubMed ID: 19106712
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.